Dual downregulation of HRK and BAD promotes BCL-xL-mediated docetaxel resistance in prostate cancer
20 August 2026 at 08:00
Oncogenesis, Published online: 20 August 2026; doi:10.1038/s41389-026-00652-y
Dual downregulation of HRK and BAD promotes BCL-xL-mediated docetaxel resistance in prostate cancer